Glucagon-Like Peptide 1 Receptor Agonist Improves Renal Tubular Damage in Mice with Diabetic Kidney Disease

References

• Ali Khan I. Do second generation sequencing techniques identify documented genetic markers for neonatal diabetes mellitus? Heliyon. 2021;7(9):e07903. doi:10.1016/j.heliyon.2021.e07903
   Web of Science ®Google Scholar
• Shaheen FA, Al-Khader AA. Epidemiology and causes of end stage renal disease (ESRD). Saudi J Kidney Dis Transpl. 2005;16(3):277–281.
   PubMedGoogle Scholar
• Zhang XX, Kong J, Yun K. Prevalence of diabetic nephropathy among patients with type 2 diabetes mellitus in china: a meta-analysis of observational studies. J Diabetes Res. 2020;2020:2315607. doi:10.1155/2020/2315607
   PubMed Web of Science ®Google Scholar
• Han J, Pang X, Shi X, Zhang Y, Peng Z, Xing Y. Ginkgo biloba extract EGB761 ameliorates the extracellular matrix accumulation and mesenchymal transformation of renal tubules in diabetic kidney disease by inhibiting endoplasmic reticulum stress. Biomed Res Int. 2021;2021:6657206. doi:10.1155/2021/6657206
   PubMed Web of Science ®Google Scholar
• Haneda M, Utsunomiya K, Koya D, et al. A new classification of diabetic nephropathy 2014: a report from joint committee on diabetic nephropathy. J Diabetes Investig. 2015;6(2):242–246. doi:10.1111/jdi.12319
   PubMed Web of Science ®Google Scholar
• Lassén E, Daehn IS. Molecular mechanisms in early diabetic kidney disease: glomerular endothelial cell dysfunction. Int J Mol Sci. 2020;21(24):9456. doi:10.3390/ijms21249456
   PubMed Web of Science ®Google Scholar
• Kunika K, Yamaoka T, Itakura M. Damage of charge-dependent renal tubular reabsorption causes diabetic microproteinuria. Diabetes Res Clin Pract. 1997;36(1):1–9. doi:10.1016/S0168-8227(97)01382-X
   Web of Science ®Google Scholar
• Zeni L, Norden AGW, Cancarini G, Unwin RJ. A more tubulocentric view of diabetic kidney disease. J Nephrol. 2017;30(6):701–717. doi:10.1007/s40620-017-0423-9
   PubMed Web of Science ®Google Scholar
• Huh JH, Lee M, Park SY, Kim JH, Lee BW. Glycated albumin is a more useful glycation index than HbA1c for reflecting renal tubulopathy in subjects with early diabetic kidney disease. Diabetes Metab J. 2018;42(3):215–223. doi:10.4093/dmj.2017.0091
   Web of Science ®Google Scholar
• Gilbert RE. Proximal tubulopathy: prime mover and key therapeutic target in diabetic kidney disease. Diabetes. 2017;66(4):791–800. doi:10.2337/db16-0796
   PubMed Web of Science ®Google Scholar
• Tang SC, Lai KN. The pathogenic role of the renal proximal tubular cell in diabetic nephropathy. Nephrol Dial Transplant. 2012;27(8):3049–3056. doi:10.1093/ndt/gfs260
   PubMed Web of Science ®Google Scholar
• Russo LM, Sandoval RM, Campos SB, Molitoris BA, Comper WD, Brown D. Impaired tubular uptake explains albuminuria in early diabetic nephropathy. J Am Soc Nephrol. 2009;20(3):489–494. doi:10.1681/ASN.2008050503
   Web of Science ®Google Scholar
• Górriz JL, Soler MJ, Navarro-González JF, et al. GLP-1 receptor agonists and diabetic kidney disease: a call of attention to nephrologists. J Clin Med. 2020;9(4):947. doi:10.3390/jcm9040947
   PubMed Web of Science ®Google Scholar
• Meier JJ. GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus. Nat Rev Endocrinol. 2012;8(12):728–742. doi:10.1038/nrendo.2012.140
   PubMed Web of Science ®Google Scholar
• Greco EV, Russo G, Giandalia A, Viazzi F, Pontremoli R, De Cosmo S. GLP-1 receptor agonists and kidney protection. Medicina. 2019;55(6):233. doi:10.3390/medicina55060233
   PubMed Web of Science ®Google Scholar
• Körner M, Stöckli M, Waser B, Reubi JC. GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting. J Nucl Med. 2007;48(5):736–743. doi:10.2967/jnumed.106.038679
   PubMed Web of Science ®Google Scholar
• Hviid AVR, Sørensen CM. Glucagon-like peptide-1 receptors in the kidney: impact on renal autoregulation. Am J Physiol Renal Physiol. 2020;318(2):F443–f454. doi:10.1152/ajprenal.00280.2019
   Web of Science ®Google Scholar
• Nolen-Doerr E, Stockman MC, Rizo I. Mechanism of glucagon-like peptide 1 improvements in type 2 diabetes mellitus and obesity. Curr Obes Rep. 2019;8(3):284–291. doi:10.1007/s13679-019-00350-4
   PubMed Web of Science ®Google Scholar
• Fan H, Pan Q, Xu Y, Yang X. Exenatide improves type 2 diabetes concomitant with non-alcoholic fatty liver disease. Arq Bras Endocrinol Metabol. 2013;57(9):702–708. doi:10.1590/S0004-27302013000900005
   PubMedGoogle Scholar
• Jia Y, Zheng Z, Guan M, et al. Exendin-4 ameliorates high glucose-induced fibrosis by inhibiting the secretion of miR-192 from injured renal tubular epithelial cells. Exp Mol Med. 2018;50(5):1–13. doi:10.1038/s12276-018-0084-3
   PubMed Web of Science ®Google Scholar
• Sancar-Bas S, Gezginci-Oktayoglu S, Bolkent S. Exendin-4 attenuates renal tubular injury by decreasing oxidative stress and inflammation in streptozotocin-induced diabetic mice. Growth Factors. 2015;33(5–6):419–429. doi:10.3109/08977194.2015.1125349
   PubMed Web of Science ®Google Scholar
• van der Aart-van der Beek AB, van Raalte DH, Guja C, et al. Exenatide once weekly decreases urinary albumin excretion in patients with type 2 diabetes and elevated albuminuria: pooled analysis of randomized active controlled clinical trials. Diabetes Obes Metab. 2020;22(9):1556–1566. doi:10.1111/dom.14067
   Web of Science ®Google Scholar
• Kodera R, Shikata K, Kataoka HU, et al. Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes. Diabetologia. 2011;54(4):965–978. doi:10.1007/s00125-010-2028-x
   PubMed Web of Science ®Google Scholar
• Amin SN, El-Gamal EM, Rashed LA, Kamar SS, Haroun MA. Inhibition of notch signalling and mesangial expansion by combined glucagon like peptide-1 agonist and crocin therapy in animal model of diabetic nephropathy. Arch Physiol Biochem. 2020;1–11. doi:10.1080/13813455.2020.1846203
   Web of Science ®Google Scholar
• Fang S, Cai Y, Lyu F, et al. Exendin-4 improves diabetic kidney disease in C57BL/6 mice independent of brown adipose tissue activation. J Diabetes Res. 2020;2020:9084567. doi:10.1155/2020/9084567
   Web of Science ®Google Scholar
• Habib HA, Heeba GH, Khalifa MMA. Effect of combined therapy of mesenchymal stem cells with GLP-1 receptor agonist, exenatide, on early-onset nephropathy induced in diabetic rats. Eur J Pharmacol. 2021;892:173721. doi:10.1016/j.ejphar.2020.173721
   Web of Science ®Google Scholar
• Jeong HY, Kang JM, Jun HH, et al. Chloroquine and amodiaquine enhance AMPK phosphorylation and improve mitochondrial fragmentation in diabetic tubulopathy. Sci Rep. 2018;8(1):8774. doi:10.1038/s41598-018-26858-8
   Web of Science ®Google Scholar
• Ma Z, Li L, Livingston MJ, et al. p53/microRNA-214/ULK1 axis impairs renal tubular autophagy in diabetic kidney disease. J Clin Invest. 2020;130(9):5011–5026. doi:10.1172/JCI135536
   PubMed Web of Science ®Google Scholar
• Pi E, Zhu C, Fan W, et al. Quantitative phosphoproteomic and metabolomic analyses reveal GmMYB173 optimizes flavonoid metabolism in soybean under salt stress. Mol Cell Proteomics. 2018;17(6):1209–1224. doi:10.1074/mcp.RA117.000417
   PubMed Web of Science ®Google Scholar
• Hou W, Zhang Y, Zhang Y, et al. Label-free proteomics study on Shewanella putrefaciens regulated by ε-Poly-lysine treatment. J Appl Microbiol. 2020;131(2):791–800.
   Web of Science ®Google Scholar
• Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol. 2008;26(12):1367–1372. doi:10.1038/nbt.1511
   PubMed Web of Science ®Google Scholar
• Selby NM, Taal MW. An updated overview of diabetic nephropathy: diagnosis, prognosis, treatment goals and latest guidelines. Diabetes Obes Metab. 2020;22(Suppl 1):3–15. doi:10.1111/dom.14007
   PubMed Web of Science ®Google Scholar
• Heinz-Taheny KM, Harlan SM, Qi Z, Heuer JG. Synopsis of sweet! Mouse models of diabetic kidney disease. Toxicol Pathol. 2018;46(8):970–975. doi:10.1177/0192623318799995
   Web of Science ®Google Scholar
• Tang SCW, Leung JCK, Lai KN. Diabetic tubulopathy: an emerging entity. Contrib Nephrol. 2011;170:124–134.
   PubMed Web of Science ®Google Scholar
• Tang SC, Chan LY, Leung JC, et al. Bradykinin and high glucose promote renal tubular inflammation. Nephrol Dial Transplant. 2010;25(3):698–710. doi:10.1093/ndt/gfp599
   PubMed Web of Science ®Google Scholar
• Ziyadeh FN, Simmons DA, Snipes ER, Goldfarb S. Effect of myo-inositol on cell proliferation and collagen transcription and secretion in proximal tubule cells cultured in elevated glucose. J Am Soc Nephrol. 1991;1(11):1220–1229. doi:10.1681/ASN.V1111220
   Web of Science ®Google Scholar
• Xue M, Yang F, Le Y, et al. Klotho protects against diabetic kidney disease via AMPK- and ERK-mediated autophagy. Acta Diabetol. 2021;58(10):1413–1423. doi:10.1007/s00592-021-01736-4
   Web of Science ®Google Scholar
• Li RX, Yiu WH, Wu HJ, et al. BMP7 reduces inflammation and oxidative stress in diabetic tubulopathy. Clin Sci. 2015;128(4):269–280. doi:10.1042/CS20140401
   Web of Science ®Google Scholar
• Yin W, Xu S, Wang Z, et al. Recombinant human GLP-1(rhGLP-1) alleviating renal tubulointestitial injury in diabetic STZ-induced rats. Biochem Biophys Res Commun. 2018;495(1):793–800. doi:10.1016/j.bbrc.2017.11.076
   Web of Science ®Google Scholar
• Li YK, Ma DX, Wang ZM, et al. The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis. Pharmacol Res. 2018;131:102–111. doi:10.1016/j.phrs.2018.03.004
   PubMed Web of Science ®Google Scholar
• Shindo M, Inui M, Kang W, et al. Deletion of a seminal gene cluster reinforces a crucial role of SVS2 in male fertility. Int J Mol Sci. 2019;20(18):4557. doi:10.3390/ijms20184557
   Web of Science ®Google Scholar
• Lundwall A, Malm J, Clauss A, Valtonen-Andre C, Olsson AY. Molecular cloning of complementary DNA encoding mouse seminal vesicle-secreted protein SVS I and demonstration of homology with copper amine oxidases. Biol Reprod. 2003;69(6):1923–1930. doi:10.1095/biolreprod.103.019984
   Web of Science ®Google Scholar